Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Option Care Health, Inc. filings document the public-company disclosures of a Nasdaq-listed provider of home and alternate-site infusion services. Its common stock is registered under the symbol OPCH, and its regulatory record includes Current Reports on Form 8-K, proxy materials, and exhibits tied to operating results and corporate actions.
OPCH filings cover quarterly and annual financial results, non-GAAP measure reconciliations, Regulation FD investor presentations, amendments to its first lien credit agreement, executive officer changes and related severance matters, and definitive proxy disclosures. The proxy record addresses board governance, stockholder voting matters, executive compensation, and capital allocation context for the company's infusion services business.
Option Care Health Inc — The Vanguard Group filed Amendment No. 4 to a Schedule 13G/A reporting 0 shares beneficially owned (representing 0% of the class) following an internal realignment. The filing cites SEC Release No. 34-39538 and states certain subsidiaries will report separately. The filing is signed by Ashley Grim on 03/27/2026.
Option Care Health director Pate R. Carter reported an open-market sale of company stock. On February 27, 2026, Carter sold 30,287 shares of Option Care Health common stock at a weighted average price of $32.0474 per share in multiple trades, leaving 11,623 shares held directly.
Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported an open-market sale of 6,000 shares of common stock at $33.00 per share. After this transaction, he directly owns 33,249 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Operating Officer Luke Whitworth reported a tax-related share disposition. On this Form 4, he transferred 4,605 shares of common stock at $33.815 per share to cover tax withholding, rather than executing an open-market sale. After this transaction, he directly holds 169,589 common shares.
Option Care Health Chief Growth Officer reports tax-related share disposition
Christopher L. Grashoff, Chief Growth Officer of Option Care Health, Inc., disposed of 1,980 shares of common stock on a tax-withholding basis at $33.815 per share. After this tax-withholding disposition, he directly holds 44,092 Option Care Health common shares.
Option Care Health, Inc. general counsel and corporate secretary Collin Smyser reported a Form 4 showing a tax-withholding disposition of 2,210 shares of common stock on February 24, 2026 at $33.815 per share. This was done to satisfy tax obligations by delivering shares rather than an open-market sale. Following this transaction, Smyser directly owned 74,560 common shares. An additional 2,500 common shares were held indirectly through a revocable trust after the reported date.
Option Care Health, Inc. Chief Medical Officer Adewunmi Femi reported a Form 4 transaction involving a tax-withholding disposition of 1,627 shares of common stock at an indicated price of $33.815 per share on February 24, 2026. After this transaction, Femi directly owned 26,710 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Executive Officer John Charles Rademacher used company stock to cover taxes on February 24, 2026. He disposed of 11,050 shares of common stock at $33.815 per share as a tax-withholding transaction and held 682,652 shares directly afterward.
Option Care Health, Inc. executive Michael Bavaro, the Chief Human Resources Officer, reported a disposition of company stock related to taxes. On this Form 4, he used 1,354 shares of common stock at $33.815 per share to cover a tax liability. After this tax-withholding transaction, he directly owned 39,249 shares of Option Care Health common stock.